DOD Biotech PCL (BKK:DOD) Research & Development: ฿0.0 Mil (TTM As of Mar. 2026)


BKK:DOD DOD Biotech PCL BKK:DOD
76 GF Score
Price ฿1.50
GF Value ฿1.67
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is DOD Biotech PCL Research & Development?

DOD Biotech PCL BKK:DOD 76 Research & Development is ฿0.0 Mil as of Mar. 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DOD Biotech PCL's Research & Development for the three months ended in Mar. 2026 was ฿0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0.0 Mil.

DOD Biotech PCL  (BKK:DOD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DOD Biotech PCL Research & Development Related Terms

DOD Biotech PCL Research & Development Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Research & Development Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:DOD
76GF Score
DOD Biotech PCL BKK:DOD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0.0 Mil mean?
DOD Biotech PCL (BKK:DOD) has a Research & Development of ฿0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's Research & Development too high?
DOD Biotech PCL's current Research & Development is ฿0.0 Mil. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Research & Development compare to KHC and GIS?
DOD Biotech PCL's Research & Development of ฿0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DOD Biotech PCL and its competitors. DOD Biotech PCL's current Research & Development is ฿0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.50 — trading 10.2% below its estimated fair value. The current Research & Development is ฿0.0 Mil. DOD Biotech PCL's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Research & Development is ฿0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.50 is trading 10.2% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.

Key valuation signals for BKK:DOD:

  • Research & Development: ฿0.0 Mil
  • GF Value™: ฿1.67 vs. price of ฿1.50 (10.2% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score

Get the complete analysis for BKK:DOD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.50
Price
฿1.67
GF Value